| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Mar'17 |
|---|---|---|---|---|---|---|---|---|---|
Collaboration revenue | |||||||||
3,988 | 3,458 | 2,858 | 2,046 | 0 | - | 0 | 0 | - | - |
Operating expenses: | |||||||||
General and administrative | |||||||||
13,285 | 12,740 | 14,106 | 14,225 | 13,036 | 11,295 | 0 | 0 | 0 | 0 |
Research and development | |||||||||
29,040 | 27,487 | 27,520 | 32,531 | 31,078 | 28,544 | 0 | 0 | 0 | 0 |
Total operating expenses | |||||||||
42,325 | 40,227 | 41,626 | 46,756 | 44,114 | 39,839 | 0 | 0 | 0 | 0 |
Loss from operations | |||||||||
-38,337 | -36,769 | -38,695 | -44,360 | -42,601 | -38,696 | 0 | 0 | 0 | 0 |
Other income: | |||||||||
Interest income | |||||||||
507 | 418 | 411 | 482 | 0 | - | 0 | 0 | - | - |
Other income and expense, net | |||||||||
-7 | 64 | 143 | 236 | 212 | 165 | 0 | 0 | 0 | - |
Total other income | |||||||||
499 | 482 | 556 | 652 | 702 | 541 | 0 | 0 | 0 | - |
Loss before provision for income taxes | |||||||||
- | - | 0 | 0 | - | - | 0 | 0 | - | - |
Provision for income taxes | |||||||||
- | - | - | 0 | - | - | - | - | - | - |
Net loss | |||||||||
-38,249 | -36,698 | -39,385 | -44,946 | -42,724 | -38,980 | 0 | 0 | 0 | 0 |
Unrealized gains (losses) from available-for-sale securities | |||||||||
262 | 0 | -9 | 0 | 0 | - | 0 | - | - | - |
Comprehensive loss | |||||||||
-37,987 | -36,698 | -39,368 | -44,957 | -42,738 | -38,991 | 0 | 0 | 0 | - |
Net loss per common share – basic and diluted | |||||||||
-0.48 | -0.35 | -0.31 | -0.46 | -0.54 | -0.59 | -0.62 | -0.36 | -0.37 | -0.31 |
Weighted average common shares outstanding – basic and diluted | |||||||||
26,569 | 24,177 | 22,450 | 20,821 | 20,718 | 20,209 | 20,132 | 20,130 | 20,063 | 10,636 |